Cargando…
Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy
Chronic cold agglutinin disease (CAD) is a subgroup of autoimmune hemolytic anemia. Primary CAD has traditionally been defined by the absence of any underlying or associated disease. The results of therapy with corticosteroids, alkylating agents and interferon-a have been poor. Cold reactive immunog...
Autores principales: | Berentsen, Sigbjørn, Beiske, Klaus, Tjønnfjord, Geir E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409172/ https://www.ncbi.nlm.nih.gov/pubmed/17891600 http://dx.doi.org/10.1080/10245330701445392 |
Ejemplares similares
-
Cold agglutinin disease: current challenges and future prospects
por: Berentsen, Sigbjørn, et al.
Publicado: (2019) -
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
por: Berentsen, Sigbjørn
Publicado: (2020) -
Sutimlimab for the Treatment of Cold Agglutinin Disease
por: Berentsen, Sigbjørn
Publicado: (2023) -
Mortality in cold agglutinin disease shows seasonal pattern
por: Hansen, Dennis Lund, et al.
Publicado: (2022) -
Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence?
por: Sefland, Øystein, et al.
Publicado: (2019)